Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany Update▲ PositiveResults31 Jul 2026

Corona Remedies Ltd

Analyst/Investor presentation

CORONA Remedies Ltd has released an investor presentation for Q1 FY27, highlighting its operational and financial performance, including revenue growth, improved ranking in the IPM, and EU-GMP certification for its Oral Solid Dosage facility.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults31 Jul 2026

Narayana Hrudayalaya Ltd.

Investor Presentation

Narayana Hrudayalaya Ltd. has released its investor presentation for Q1 FY27, highlighting its operational and financial performance. The company reported a 78.0% YoY increase in consolidated operating revenues to ₹ 26,836 Mn and a 18.8% EBITDA margin. Narayana Health has expanded its footprint with new facilities and services, including robotic surgery capabilities.

Read more →📎 1 attachment
BSEBoard Meeting▲ PositiveResults31 Jul 2026

Aarti Drugs Ltd

Financial Results for the quarter ended June 30, 2026

Aarti Drugs Ltd announced its audited standalone and consolidated financial results for the quarter ended June 30, 2026, with a profit before exceptional items and tax of ₹6,994. The company reported a revenue from operations of ₹70,278 and a total income of ₹72,030. The financial results were approved by the Board of Directors in their meeting held on July 31, 2026.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults31 Jul 2026

Glenmark Pharmaceuticals Ltd

Investor Presentation - Q1 FY 26-27

Glenmark Pharmaceuticals Ltd has reported Q1 FY27 results with consolidated revenue of Rs. 40,185 million, a 23.1% YoY growth, driven by broad-based growth across key markets, with India, North America, and Emerging Markets delivering strong performance.

Read more →📎 1 attachment
NSEUpdates▲ PositiveResults31 Jul 2026

Glenmark Pharmaceuticals Limited

Updates

Glenmark Pharmaceuticals Limited has informed the Exchange regarding 'Investor Presentation' for Q1 FY 27, with consolidated revenue of Rs. 40,185 million, a 23.1% YoY growth, and EBITDA of Rs. 8,048 million with a margin of 20.03%. The company has reported strong growth across its key markets, with India business growth of 15.5%, North America core business growth of 19.8%, and Emerging Markets business growth of 27.7%. The results reinforce the direction of Glenmark's next phase: strengthening its core businesses while expanding its differentiated specialty and innovation-led platforms.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults31 Jul 2026

Glenmark Pharmaceuticals Limited

Press Release

Glenmark Pharmaceuticals Limited has announced its Q1 FY27 results, with consolidated revenue growing 23.1% YoY to Rs. 40,185 million, driven by strong execution and resilience of its business. The company reported EBITDA of Rs. 8,048 million, a 38.6% YoY growth, and PAT of Rs. 4,828 million, with a PAT margin of 11.8%. The company's India formulations revenue grew 15.5% YoY, North America revenue grew 41.1% YoY, and Emerging Markets revenue grew 27.7% YoY.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults31 Jul 2026

Glenmark Pharmaceuticals Ltd

Please find attached Press Release and Management Discussion & Analysis for the first quarter ended June 30, 2026

Glenmark Pharmaceuticals Ltd has announced its Q1 FY27 results, with consolidated revenue growing 23.1% YoY to Rs. 40,185 million, driven by strong growth in India, North America, and Emerging Markets. EBITDA was Rs. 8,048 million, with a margin of 20.03%, and PAT was Rs. 4,828 million, with a margin of 11.8%. The company has also highlighted its focus on strengthening its core businesses and expanding its specialty and innovation-led platforms.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults31 Jul 2026

Blue Dart Express Limited

Outcome of Board Meeting

Blue Dart Express Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, along with a limited review report from its statutory auditors. The results include a net profit of ₹8,668 and a dividend of ₹25 per equity share for the financial year ended March 31, 2026.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults31 Jul 2026

Yasho Industries Limited

Press Release

Yasho Industries Limited has announced its unaudited financial results for Q1 FY27, with revenue of ₹307.74Cr, a 42% YoY increase, driven by additional off-take by existing customers and acquisition of marquee international customers. EBITDA margin improved to 24.2% and PAT margin to 11.7%, driven by optimized product mix, cost discipline, and operating efficiencies.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults31 Jul 2026

Viceroy Hotels Limited

Press Release

Viceroy Hotels Limited has announced its unaudited financial results for the quarter ended June 30, 2026, showing a 70.8% year-over-year growth in total income to ₹45.2 Cr, with EBITDA increasing 144.5% YoY to ₹11.8 Cr and PAT standing at ₹1.4 Cr, recording a growth of 147.9%.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults31 Jul 2026

Viceroy Hotels Ltd

Press Release for the period ended 30.06.2026.

Viceroy Hotels Ltd reported a strong Q1 FY27 financial performance, with total income growing 70.8% YoY to ₹45.2 Cr, and EBITDA increasing 144.5% YoY to ₹11.8 Cr. The company's Executive Apartments business delivered a 19% increase in room revenue during the period. The Managing Director & CEO, Mr. Ravinder Reddy Kondareddy, attributed the strong performance to enhanced operational efficiencies and disciplined execution.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults31 Jul 2026

Sanghvi Movers Limited

Investor Presentation

Sanghvi Movers Limited has informed the Exchange about Investor Presentation on unaudited financial results for the quarter ended June 30, 2026. The presentation highlights a robust 40% year-on-year growth in Q1 FY27 with total income of ₹393 crore and a strong order book of ₹1,253 crore.

Read more →📎 1 attachment
BSEOthers▲ PositiveResults31 Jul 2026

NGL Fine Chem Ltd

Submission of Annual Report as per Reg. 34 (1)

NGL Fine Chem Ltd has submitted its annual report for FY26, showing a 36% increase in revenue to ₹500.95 crores, with EBITDA more than doubling to ₹72.69 crores and profit after tax growing 128% to ₹48.13 crores. The company has also reported a 73% increase in manufacturing facilities to 20,000 m2 and a 4.19 million MT increase in green fuel adoption.

Read more →📎 1 attachment
NSECopy of Newspaper Publication▲ PositiveResults31 Jul 2026

BLACKBUCK LIMITED

Copy of Newspaper Publication

Vedanta reports Q1 FY27 net profit up 72% at ₹5,473 crore, driven by better realisation from zinc and metal production, and increased production at Gamsberg and Black Mountain mines. The company plans to demerge its surplus real estate assets into a separate company, Vedanta Property Platforms, to unlock value.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults31 Jul 2026

ABB India Ltd

Please refer enclosed file

ABB India Ltd has announced its unaudited financial results for the second quarter ended June 30, 2026, with record orders, robust revenue, and resilient profitability. The company reported a 36% increase in orders, 13% increase in revenue, and 22% increase in backlog. The operational EBITA margin was 50.0% and the net profit margin was 70.0%. The company also announced a special dividend.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults31 Jul 2026

ABB India Limited

Investor Presentation

ABB India Limited has announced its Q2 CY2026 results, with record orders, robust revenue, and resilient profitability. The company has reported a 36% increase in orders, 13% increase in revenue, and 22% increase in backlog. The operational EBITA margin has improved to 50.0%, and the company has declared a special dividend. The company has also highlighted its commitment to sustainability, with a 85% reduction in Scope 1 and 2 GHG emissions and a 99.7% 'Strong' ESG rating from CRISIL.

Read more →📎 1 attachment
BSEOthers▲ PositiveResults31 Jul 2026

Astral Ltd

Annual Report FY 2025-26

Astral Ltd has released its annual report for FY 2025-26, highlighting a 9.5% increase in revenue from operations to ₹65,686 million, and a 9.1% increase in EBITDA to ₹11,092 million. The company has also announced its 30th Annual General Meeting to be held on August 24, 2026.

Read more →📎 1 attachment
← PreviousPage 444 of 536Next →